Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Singapore To Make H1N1 Flu Shots Voluntary Amid Side Effect Concerns

This article was originally published in PharmAsia News

Executive Summary

Singapore, yet to feel the onslaught of the H1N1 influenza virus, has decided to make vaccinations voluntary. Once available, the vaccine is to be sold at general-practitioner clinics, similar to the way drugs against the seasonal flu are handled. The Ministry of Health said it decided to make the shots voluntary because the vaccine might have side effects not yet discovered. The ministry noted the 1976 problem in the United States when people developed Guillain-Barre syndrome after being given a vaccine rushed into use. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel